ホームページへ
820К+ 2014年以降患者がサポートを受けています
50
1,500 クリニック
6K+ レビュー
3K+ 3,000名以上の資格を持つ医師

ポーランドでの鼻咽頭癌診断・治療費用について今すぐご確認ください

料金はお問い合わせください
ポーランドトルコオーストリア
ハルシオン-から $5,400-
データは2026年June月時点でBookimedにより検証され、世界90件のクリニックからの患者リクエストと公式見積もりに基づいています。中央値費用は実際の請求書(2024年-2026年)に基づいており毎月更新されます。実際の価格は異なる場合があります。

Bookimedでのお客様のメリットと保証

直接価格

Bookimedは鼻咽頭癌治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。

検証済みクリニック・医師のみ

Bookimedはお客様の安全に取り組んでいます。鼻咽頭癌治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。

無料24時間365日サポート

Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。鼻咽頭癌治療の旅路でお一人になることはありません。

なぜ当社を?

Bookimed専属アシスタント

  • すべての段階でサポート
  • 適切なクリニックと医師の選択をサポート
  • 迅速で便利な情報アクセスを確保

このコンテンツを共有

Bookimed患者のビデオストーリー

Dayana
I combined my vacation in Antalya with a check-up.
治療: 女性検査
クリニック: Memorial Antalya Hospital
Igor
It was great! Transfers, accommodation, treatment—all included.
治療: 歯科インプラント
クリニック: WestDent Clinic
Marina
Bookimed did everything for me. I didn't have to worry about anything.
治療: 女性検査
クリニック: Severance Hospital
更新済み: 05/27/2022
著者
アンナ・レオノヴァ
アンナ・レオノヴァ
コンテンツマーケティングチーム責任者
10年以上の経験を持つ認定医療ライターで、文学修士号を持ち、世界中の医療専門家のインタビューに基づくBookimedの信頼できるコンテンツを開発しています。
Fahad Mawlood
医学編集者・データサイエンティスト
一般開業医。4つの科学賞受賞。西アジアでの勤務経験。アラビア語を話す患者様をサポートする医療チームの元チームリーダー。現在はデータ処理と医療コンテンツの正確性を担当
Fahad Mawlood Linkedin
このページは、さまざまな国で利用可能な各種医療状態、治療、ヘルスケアサービスに関する情報を掲載する場合があります。コンテンツは情報提供のみを目的として提供されており、医療アドバイスやガイダンスとして解釈されるべきではないことをご承知おきください。医療治療を開始または変更する前に、医師または資格のある医療専門家にご相談ください。

ポーランドでの鼻咽頭癌治療に関するFAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

What are the primary treatment methods used for nasopharyngeal cancer in Poland?

Nasopharyngeal cancer treatment in Poland centers on non-surgical methods like intensity-modulated radiotherapy (IMRT) and platinum-based chemotherapy. Polish oncological centers follow international ESMO-EURACAN protocols. Multidisciplinary consultations help coordinate personalized care pathways while preserving vital surrounding structures and functions.

  • Radiotherapy standards: IMRT is the gold standard for delivering 66–70 Gy to tumors.
  • Systemic therapy: Doctors combine concurrent cisplatin with radiation for stages II through IVA.
  • Diagnostic tools: Specialists utilize PET/CT and sinus CT for precise staging and localization.
  • Surgical salvage: Experts reserve endoscopic nasopharyngectomy only for persistent or recurrent local disease.

Bookimed Expert Insight: Patients with heart conditions find specialized care at European Health Center Otwock near Warsaw. This facility operates Poland's only Interdisciplinary Cardio-oncology Department. This setup is vital because aggressive chemotherapy can affect cardiac health. Choosing a center with integrated cardiology ensures doctors monitor your heart throughout the cancer treatment process.

Patient Consensus: Patients note that standard treatment usually skips surgery in favor of concurrent chemo-radiation. Many emphasize starting swallowing exercises and dental protection early to manage long-term dry mouth or jaw stiffness.

Are modern options such as immunotherapy and targeted therapy available for nasopharyngeal cancer in Poland?

Nasopharyngeal cancer patients in Poland can access immunotherapy and targeted therapy through public and private pathways. Specialists utilize immune checkpoint inhibitors like Nivolumab and Pembrolizumab for recurrent cases. Access often requires treatment at tertiary oncology centers or participation in clinical trials.

  • Immunotherapy drugs: Nivolumab and Pembrolizumab are used for recurrent head and neck cancers.
  • Access protocols: Doctors use the RDTL program for fast-track access to new drugs.
  • Targeted therapy: EGFR inhibitors are typically combined with chemoradiation for advanced stages.
  • Precision diagnostics: PET/CT and biopsy are standard for staging and treatment planning.

Bookimed Expert Insight: Patients seeking the most advanced systemic treatments should prioritize private oncology centers near Warsaw. European Health Center Otwock, for example, is the first private hospital in Poland specializing in oncology. These facilities often bypass the bureaucratic wait times found in the public system for newer drug protocols.

Patient Consensus: Patients note that access to modern therapies depends heavily on being treated at a major academic center. They recommend being proactive by requesting EBV testing and asking about multidisciplinary tumor boards early in the process.

Which Polish medical facilities are recognized for advanced head-and-neck oncology care?

Poland provides advanced head and neck oncology through specialized national institutes and university hospitals. These facilities utilize precision diagnostics like PET/CT and CT of the paranasal sinuses. Centers in Warsaw, Poznan, and Gliwice specialize in complex nasopharyngeal cancer protocols including proton beam therapy and robotic radiosurgery.

  • Specialized facilities: Maria Sklodowska-Curie National Research Institute offers multimodal care across three branches.
  • Radiotherapy expertise: Centrum CyberKnife in Wieliszew provides robotic radiosurgery for hard-to-reach tumors.
  • Multidisciplinary teams: Greater Poland Cancer Centre coordinates multi-specialty tumor boards for pharyngeal cases.
  • Diagnostic precision: European Health Center Otwock prioritizes minimal wait times for advanced staging diagnostics.

Bookimed Expert Insight: While many search for large public institutes, European Health Center Otwock stands out for its cardio-oncology focus. This is vital for nasopharyngeal patients, as intensive chemoradiation requires careful heart monitoring. Selecting a facility with this crossover avoids shifting between different hospitals during aggressive treatment cycles.

Patient Consensus: Patients emphasize that treatment coordination is a key quality marker for complex cases. They note that having ENT, oncology, and pathology in one pathway simplifies the difficult recovery process.

What is the DiLO (Diagnosis and Oncology Treatment Card) system, and does it affect international patients?

The DiLO card is a fast-track diagnostic document used in Poland public healthcare system. It acts as a green pass for cancer care. This system bypasses standard waiting lists for insured patients. It aims to start treatment within seven to nine weeks of suspicion.

  • System eligibility: Access depends on Polish public health insurance (NFZ) status.
  • Access for residents: Foreign residents paying NFZ contributions have full card access.
  • EU mobility: European Health Insurance Card (EHIC) holders may access it for emergencies.
  • Private care impact: Private patients bypass DiLO as private clinics operate independently.

Bookimed Expert Insight: While DiLO is vital for public care, international patients seeking treatment at private centers like European Health Center Otwock find faster pathways without it. Private clinics do not have budget caps. This allows immediate access to specialized Interdisciplinary Cardio-oncology for patients with heart complications. This speed is often more predictable than navigating the administrative requirements of the public green card system.

Patient Consensus: Patients note that DiLO is an administrative tool rather than a treatment itself. They emphasize that while it helps prioritize cases, delays can still happen if pathology reports or imaging documents are missing or not translated.

無料相談を受ける

最適な連絡方法をお選びください